Add to ORKGLow-molecular-weight-heparin (LMWH) has been widely used in the treatment of acute ischemic stroke but controlled trials are few. In this study, 40 patients with acute ischemic stroke of less than 24 hours duration were randomized to receive either aspirin (325 mg/day) alone or aspirin (325 mg/day) plus subcutaneous nadroparin 4100 units/day. At the end of 4 weeks, the morbidity and mortality were significantly less in the nadroparin group as compared to the aspirin group. There was no increased risk of clinically significant intracranial hemorrhage in either group. The combination of aspirin and LMWH deserves to be tested in larger studies
Background and Purpose-The combination of low-dose aspirin and dipyridamole is more effective than a...
Anthithrombotic therapy is widely used as primary and secondary preventative treatment for ischemic ...
Background and Purpose—This meta-analysis systematically reviewed randomized controlled trials compa...
Low-molecular-weight-heparin (LMWH) has been widely used in the treatment of acute ischemic stroke b...
Background and Purpose—The Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tri...
Randomised controlled trial Aspirin plus clopidogrel in acute minor ischaemic stroke or transient is...
In ischaemic stroke, thrombolytic drugs speed the recanalisation of intracerebral arteries. The effe...
The numerous large-scale randomized clinical trials performed during the last decade on either unfra...
Objectives: To determine efficacy and tolerability of aspirin plus dipyridamole (combination) versus...
Escola Paulista de Medicina Department of Internal MedicineUNIFESP, EPM, Department of Internal Medi...
Antiplatelets represent a diverse group of agents that share the ability to reduce platelet activity...
Aspirin reduces the occurrence of ischemic strokes. In some prophylactic trials it was suggested tha...
Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke ...
AbstractAntithrombotic therapy is clearly beneficial in the treatment of acute myocardial infarction...
Background and Purpose—Patients with stroke are at substantial risk of thromboembolic complications ...
Background and Purpose-The combination of low-dose aspirin and dipyridamole is more effective than a...
Anthithrombotic therapy is widely used as primary and secondary preventative treatment for ischemic ...
Background and Purpose—This meta-analysis systematically reviewed randomized controlled trials compa...
Low-molecular-weight-heparin (LMWH) has been widely used in the treatment of acute ischemic stroke b...
Background and Purpose—The Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tri...
Randomised controlled trial Aspirin plus clopidogrel in acute minor ischaemic stroke or transient is...
In ischaemic stroke, thrombolytic drugs speed the recanalisation of intracerebral arteries. The effe...
The numerous large-scale randomized clinical trials performed during the last decade on either unfra...
Objectives: To determine efficacy and tolerability of aspirin plus dipyridamole (combination) versus...
Escola Paulista de Medicina Department of Internal MedicineUNIFESP, EPM, Department of Internal Medi...
Antiplatelets represent a diverse group of agents that share the ability to reduce platelet activity...
Aspirin reduces the occurrence of ischemic strokes. In some prophylactic trials it was suggested tha...
Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke ...
AbstractAntithrombotic therapy is clearly beneficial in the treatment of acute myocardial infarction...
Background and Purpose—Patients with stroke are at substantial risk of thromboembolic complications ...
Background and Purpose-The combination of low-dose aspirin and dipyridamole is more effective than a...
Anthithrombotic therapy is widely used as primary and secondary preventative treatment for ischemic ...
Background and Purpose—This meta-analysis systematically reviewed randomized controlled trials compa...